Showing results (1011-1020 of 1,547) with videos related to
Sort By:
Pageof 155
Nature Reviews. Clinical Oncology|April 21, 2023
Understanding the activity of antibody-drug conjugates in primary and secondary brain tumoursMaximilian J Mair, Rupert Bartsch, Emilie Le Rhun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid CancerVivek Subbiah, Robert J Kreitman, Zev A Wainberg, et al.JNCI Cancer Spectrum|July 31, 2019
The Landscape of Somatic Genetic Alterations in Breast Cancers from <i>CHEK2</i> Germline Mutation CarriersDiana Mandelker, Rahul Kumar, Xin Pei, et al.Histopathology|July 31, 2019
Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breastFrancisco Beca, Simon S K Lee, Fresia Pareja, et al.International Journal of Radiation Oncology, Biology, Physics|March 27, 2026
Molecular risk stratification for decision-making among patients with breast cancer eligible to omit radiotherapyShoshana J Rosenzweig, Lillian A Boe, Hannah Y Wen, et al.Practical Radiation Oncology|May 24, 2016
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice GuidelineAlvin R Cabrera, John P Kirkpatrick, John B Fiveash, et al.Neuro-Oncology|June 26, 2021
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumorsTobias Walbert, Rebecca A Harrison, David Schiff, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 17, 2008
Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseasesH-C Bi, Z Zuo, X Chen, et al.Neuro-Oncology|November 9, 2021
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenibBenjamin M Ellingson, Grace Hyun J Kim, Matt Brown, et al.Cancer|November 21, 2019
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancerAlice Y Ho, Christopher A Barker, Brittany B Arnold, et al.Pageof 155